Violations of Exhibiting and FDA Rules at an American Psychiatric Association Annual Meeting

Authors from Public Citizen Health Research Group describe how pharmaceutical companies violate FDA rules and those of the American Psychiatric Association as they present their products at the Association's annual meeting.

Peter Lurie, Tung Tran, Sidney Manuel Wolfe and Robert Goodman

J Public Health Pol 26: 389-399; doi:10.1057/palgrave.jphp.3200049

Abstract | PDF

Commentary

The Professional Society Circus

The former editor of the New England Journal of Medicine and author of a new book, On the Take: how medicine's complicity with big business can endanger your health, comments on just how pervasive these banned practices are.

Jerome P Kassirer

J Public Health Pol 26: 400-403; doi:10.1057/palgrave.jphp.3200048

Abstract | PDF

Controversies and Speed Cameras: Lessons Learnt Internationally

A multinational group of researchers examines the effects of speed cameras on the prevalence of speeding and of the contribution of speed cameras to reducing motor vehicle injuries and deaths.

Amanda Delaney, Heather Ward, Max Cameron and Allan F Williams

J Public Health Pol 26: 404-415; doi:10.1057/palgrave.jphp.3200044

Abstract | PDF

Commentary

It is Speed that Kills

Ben Kelley

J Public Health Pol 26: 416-417; doi:10.1057/palgrave.jphp.3200046

Abstract | PDF

The United States Health Centers Initiative: A State by State Status Report

In 2001 the US decided to help people with limited access to medical care by expanding health centers. The author reports on how the Health Resources and Services Administration is monitoring progress.

Robert M Politzer

J Public Health Pol 26: 418-429; doi:10.1057/palgrave.jphp.3200051

Abstract | PDF

Confidentiality and Confidence: Is Data Aggregation a Means to Achieve Both?

In response to increasingly computerized medical records, the US Government has mandated privacy protections. The authors look at the ways that privacy is being protected and consider the consequences for those who would use these data that have been subjected to aggregation and other manipulations.

Nina H Fefferman, Eileen A O'Neil and Elena N Naumova

J Public Health Pol 26: 430-449; doi:10.1057/palgrave.jphp.3200029

Abstract | PDF

Philip Morris' FDA Gambit: Good for Public Health?

A professor of political science speculates about what was happening when the largest US tobacco company supported legislation that would have further regulated the tobacco industry.

Michael Givel

J Public Health Pol 26: 450-468; doi:10.1057/palgrave.jphp.3200032

Abstract | PDF